유방 보존 수술 시장 규모, 점유율, 동향 분석 리포트 : 시술별, 제품별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Breast-conserving Surgery Market Summary

The global breast-conserving surgery market size was estimated at USD 2.45 billion in 2024 and is projected to reach USD 4.58 billion by 2033, growing at a CAGR of 7.26% from 2025 to 2033. The growth is attributed to the rising incidence of breast cancer and a growing emphasis on early detection and intervention.

There is an increasing preference among patients for procedures that preserve both cosmetic appearance and breast function, driving demand for less invasive surgical options. For instance, according to a report by the American Cancer Society, in 2024, an estimated 310,720 new cases of invasive breast cancer and 56,500 cases of ductal carcinoma in situ (DCIS) are expected to be diagnosed among women in the U.S. Additionally, 42,250 women are projected to lose their lives to breast cancer. The rising preference for cosmetic and functional preservation drives growth in the breast-conserving surgery (BCS) market.

Unlike traditional mastectomy, which involves the complete removal of the breast, BCS focuses on excising the tumor while retaining as much of the natural breast tissue and appearance as possible. This approach aligns with the increasing demand from patients, especially younger women, for procedures that not only treat cancer effectively but also maintain physical aesthetics, body image, and quality of life. Functional benefits such as preserved sensation and less physical trauma contribute to improved emotional well-being and postoperative satisfaction.

The rising prevalence of breast cancer is a primary driver of the BCS market, as it directly increases the number of patients requiring surgical intervention. With improved awareness, widespread screening programs, and advancements in diagnostic technologies, more breast cancers are being detected at earlier stages-making a larger proportion of patients eligible for breast-conserving procedures instead of full mastectomy. Early-stage diagnosis not only supports better outcomes but also aligns with growing patient preferences for less invasive treatments that preserve breast appearance and function. As the global burden of breast cancer continues to rise, healthcare systems are increasingly integrating BCS into standard care pathways, fueling demand for specialized surgical tools, localization technologies, and post-operative care solutions.

Technological advancements in wireless localization and AI-based margin assessment are revolutionizing the breast-conserving surgery (BCS) market, significantly improving surgical precision, reducing reoperation rates, and enhancing patient outcomes. Traditionally, wire-guided localization was used to pinpoint tumor sites, but this method posed several challenges, such as patient discomfort, scheduling constraints, and the risk of wire displacement. In contrast, wireless localization systems (e.g., RFID or magnetic seed-based technologies) offer greater flexibility, improved accuracy, and a better overall surgical experience for both patients and surgeons.

Simultaneously, AI-powered margin assessment tools are transforming intraoperative decision-making. These technologies analyze tissue samples in real-time to determine if cancerous cells remain at the surgical margins, allowing surgeons to make immediate adjustments and achieve clean margins during the first procedure. This greatly reduces the need for second surgeries, shortens recovery time, and improves clinical efficiency.

Global Breast-conserving Surgery Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast-conserving surgery market report on the basis of procedure, product, end use, and region:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Lumpectomy
• Quadrantectomy
• Segmental Mastectomy
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Tumor Localization Devices
  • Wire-guided localization
  • Magnetic seed localization
  • Radar-based localization
  • Others
• Surgical Excision Devices
  • Electrosurgical units/devices
  • Scalpels/forceps/retractors/clamps
  • Vacuum-assisted biopsy systems
  • Others
• Margin Assessment Devices
• Intraoperative Imaging & Navigation Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Oncology/Specialty Clinics
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
• 1.15. Approach 1: Commodity flow approach
• 1.16. Volume price analysis (Model 2)
• 1.17. Approach 2: Volume price analysis
• 1.18. List of Secondary Sources
• 1.19. List of Primary Sources
• 1.20. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast-Conserving Surgery Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing breast cancer incidence and focus on early detection
    • 3.2.1.2. Rising preference for cosmetic and functional preservation
    • 3.2.1.3. Technological advancement in wireless localization and AI-based margin assessment
    • 3.2.1.4. Growth of ambulatory surgical settings
    • 3.2.1.5. Favorable government and reimbursement support in developed nations
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of advanced technologies
    • 3.2.2.2. Limited access to early diagnosis
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Breast-Conserving Surgery Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Breast-Conserving Surgery Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Breast-Conserving Surgery Market: Procedure Movement Analysis & Market Share, 2024 & 2033
• 4.3. Lumpectomy
  • 4.3.1. Lumpectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Quadrantectomy
  • 4.4.1. Quadrantectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Segmental Mastectomy
  • 4.5.1. Segmental Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast-Conserving Surgery Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Breast-Conserving Surgery Market: Product Movement Analysis & Market Share, 2024 & 2033
• 5.3. Tumor Localization Devices
  • 5.3.1. Tumor Localization Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Wire-Guided Localization
    • 5.3.2.1. Wire-guided localization market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.3.3. Magnetic Seed Localization
    • 5.3.3.1. Magnetic seed localization market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.3.4. Radar-Based Localization
    • 5.3.4.1. Radar-based localization market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.3.5. Others
    • 5.3.5.1. Others market estimates and forecasts 2018 to 2033 (USD Million)
• 5.4. Surgical Excision Devices
  • 5.4.1. Surgical Excision Devices Market Estimates And Forecasts 2018 to 2033 (USD Million)
  • 5.4.2. Electrosurgical Units/Devices
    • 5.4.2.1. Electrosurgical units/devices market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.4.3. Scalpels/Forceps/Retractors/Clamps
    • 5.4.3.1. Scalpels/forceps/retractors/clamps market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.4.4. Vacuum-Assisted Biopsy Systems
    • 5.4.4.1. Vacuum-assisted biopsy systems market estimates and forecasts 2018 to 2033 (USD Million)
  • 5.4.5. Other
    • 5.4.5.1. Other market estimates and forecasts 2018 to 2033 (USD Million)
• 5.5. Margin Assessment Devices
  • 5.5.1. Margin Assessment Devices Market Estimates And Forecasts 2018 to 2033 (USD Million)
• 5.6. Intraoperative Imaging & Navigation Devices
  • 5.6.1. Intraoperative Imaging & Navigation Devices Market Estimates And Forecasts 2018 to 2033 (USD Million)

Chapter 6. Breast-Conserving Surgery Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Breast-Conserving Surgery Market: End Use Movement Analysis & Market Share, 2024 & 2033
• 6.3. Hospitals
  • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Ambulatory Surgery Centers
  • 6.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Oncology/Specialty Clinics
  • 6.5.1. Oncology/Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast-Conserving Surgery Market: Regional Estimates & Trend Analysis by Product, Procedure, End Use

• 7.1. Regional Outlook
• 7.2. Breast-Conserving Surgery Market: Regional Movement Analysis & Market Share, 2024 & 2033
• 7.3. North America
  • 7.3.1. North America Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Scenario
    • 7.3.4.4. Reimbursement Scenario
    • 7.3.4.5. Mexico Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Denmark Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Sweden Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Argentina Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Breast-Conserving Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Hologic, Inc
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Dilon Technologies
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Argon Medical Devices
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Merit Medical Systems
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. KUBTEC
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Stryker
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. SamanTree Medical
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Perimeter Medical Imaging AI
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Xeos
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. BD
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. Mammotome (Danaher)
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Product Benchmarking
    • 8.2.11.4. Strategic Initiatives
  • 8.2.12. CairnSurgical Inc.
    • 8.2.12.1. Company Overview
    • 8.2.12.2. Financial Performance
    • 8.2.12.3. Product Benchmarking
    • 8.2.12.4. Strategic Initiatives
  • 8.2.13. Innoblative Designs
    • 8.2.13.1. Company Overview
    • 8.2.13.2. Financial Performance
    • 8.2.13.3. Product Benchmarking
    • 8.2.13.4. Strategic Initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2024